Redefining the Management of Diabetes: A Review of Quality and Individualizing Patient Care
This Continuing Education activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc
This activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc
Jennifer Costello, PharmD, BCPS, BC-ADM
Assistant Director of Clinical Services
for the Pharmacy Department
Residency Program Director
Saint Barnabas Medical Center
After completing this continuing education program, the participant will be able to:
- Review clinical practice guidelines and standards of care in the management of type 2 diabetes mellitus.
- Examine comprehensive treatment plans for patients with diabetes that focus on individualization.
- Document recommendations, benefits, risks, limitations, and controversies surrounding pharmacologic therapy with insulin.
- Adopt programs focused on achieving clinical metrics and improving patient outcomes.
Target audience: Pharmacists
Type of activity: Application
Release date: June 7, 2015
Expiration date: June 7, 2017
Estimated time to complete activity: 2.0 hours
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-050-H01-P. The activity is available for CE credit through June 7, 2017.